NEW!

Monday, April 18
Scientific Platform Sessions
3:30 p.m.–5:30 p.m. Scientific Platform Sessions
S24: Clinical Outcomes and
Treatment Strategies in
Multiple Sclerosis
3:30 p.m. S24.001
Predicting the End of Symptomatic
Relapses and Disease Modifying
Treatment Use Decisions in Progressive
Multiple Sclerosis —Martina Novotna,
Brittani Conway, Burcu Zeydan, M. Paz
Soldan, Nuhad Abou Zeid, Nilufer Kale,
Melih Tutuncu, Orhun Kantarci
3:45 p.m. S24.002
Can We Stop Immunomodulatory
Treatment in Secondary Progressive
MS? —Julien Bonenfant, Veronique
Deburghgraeve, Emmanuelle Le Page,
Gilles Edan, Anne Kerbrat, Bajeux Emma
4:00 p.m. S24.003
Switch Strategies in RRMS: A Real-Life
Multi Center Study —Francesco Sacc,
Alessio Signori, Giorgia Teresa Maniscalco,
Roberta Lanzillo, Salvatore Lo Fermo,
Pietro Annovazzi, Luca Prosperini, Eleonora
Cocco, Simona Bonavita, Valentina Torri
Clerici, Alice Laroni, Anna Maria Repice,
Ignazio Roberto Zarbo, Cerqua Raffaella,
Alessia Di Sapio, Simona Pontecorvo,
Marinella Clerico, Luigi Lavorgna, Caterina
Barrillà, Cinzia Cordioli, Fabio Gallo, Maria
Pia Sormani
4:15 p.m. S24.004
Comparison of Fingolimod and Dimethyl
Fumarate in the Treatment of Multiple
Sclerosis: Two Year Experience —
Brandi Vollmer, Kavita Nair, Stefan Sillau,
John Corboy, Timothy Vollmer, Enrique
Alvarez
4:30 p.m. S24.005
Interferon-Beta Exposure During First
Trimester in Women with Multiple
Sclerosis - A Prospective Cohort Study
from the German Multiple Sclerosis
and Pregnancy Registry —Sandra Thiel,
Sylvia Menck, Birte Elias-Hamp, Ralf Gold,
Kerstin Hellwig
4:45 p.m. S24.006
Pregnancy and Fetal Outcomes After
In Utero Exposure to Natalizumab in
Patients with Multiple Sclerosis: A
Prospective, Nation-Wide, Controlled
Study —Marta Giannini, Emilio Portaccio,
Bahia Hakiki, Pasto' Luisa, Lorenzo
Razzolini, Righini Isabella, Carla Tortorella,
Maria Trojano, Eleonora Cocco, Maurizio
Melis, Marrosu Maria Giovanna, Valeria
Di Tommaso, Deborah Farina, Alessandra
Lugaresi, Pietro Annovazzi, Angelo Ghezzi,
Claudio Gasperini, Alfonso Iudice, Roberta
Fantozzi, Paolo Bellantonio, Silvia Messina,
Francesco Patti, Chiavazza Carlotta, Paola
Cavalla, Alessandra Protti, Rocco Totaro,
Carlo Pozzilli, Laura De Giglio, Antonio
Uccelli, Arianna Sartori, Antonio Bosco,
Roberta Lanzillo, Vincenzo Brescia Morra,
Maria Pia Amato
5:00 p.m. S24.007
Age Related Multiple Sclerosis
Severity Score: Disability Ranked by
Age —Ali Manouchehrinia, Westerlind
Helga, Elaine Kingwell, Feng Zhu, Robert
Carruthers, Ryan Ramanujam, Ban Maria,
Anna Glaser, Stephen Sawcer, Helen
Tremlett, Jan Hillert
5:15 p.m. S24.008
Pregnancy Outcomes in Patients with
RRMS Who Received Alemtuzumab in
the Clinical Development Program —
Jiwon Oh, Anat Achiron, Christina
Chambers, Edward Fox, Pamela McCombe,
Susana Otero, David Margolin, Linda
Kasten, D Alastair Compston
S25: Movement Disorders:
Huntington's Disease
3:30 p.m. Presentation of the
Movement Disorders Research
Award
Sponsored by the American Academy of
Neurology and the Parkinson’s Disease
Foundation through an endowment.
Recipient:
Susan B. Bressman, MD, FAAN
New York, NY
4:00 p.m. S25.003
Intermediate CAG Repeats in
Huntington´s Disease. A Longitudinal
Analysis of the European Huntington´s
Disease Network REGISTRY Cohort —
Esther Cubo, Maria Antonia Ramos-Arroyo,
Saul Martinez-Horta, Asunción Martinez-
Descalls, Cecilia Gil-Polo
4:15 p.m. S25.004
PRE-CELL: Clinical and Novel Biomarker
Measures of Disease Progression in
a Lead-In-Observational Study for a
Planned Phase 1 Trial of Genetically-
Modified Mesenchymal Stem Cells
Over-Expressing BDNF in Patients with
Huntington’s Disease —Vicki Wheelock,
Teresa Tempkin, Alexandra Duffy, Amanda
Martin, Lisa Mooney, Ashok Dayananthan,
Lorin Scher, Sarah Farias, David Swadell,
Charles DeCarli, James Brunberg, Chin-
Shang Li, Yu Liu, Mark Yarborough, Julie
Stout, miriam Moscovitch-Lopatin, Steven
Hersch, Kyle Fink, Geralyn Annett, Jan
Nolta
4:30 p.m. S25.005
Enroll-HD: A Global Clinical Research
Platform for Huntington’s Disease —
Tiago Mestre, Cheryl Fitzer-Attas, Joseph
Giuliano, Bernhard Landwehrmeyer,
Cristina Sampaio
4:45 p.m. S25.006
Rating Swallowing Function in Patients
with Huntington Disease Enrolled in
the First-HD Study —Daniel Claassen,
Samuel Frank, David Stamler, Victor Sung,
Sarah Janicki, David Oakes, Christina
Vaughan, Claudia Testa
5:00 p.m. S25.007
Mesenchymal Stem Cells Engineered
to Overexpress Brain-Derived
Neurotrophic Factor As a Proposed
Therapeutic for Huntington’s
Disease —Vicki Wheelock, Kari Pollock,
Heather Dahlenberg, Hayley Nelson, Kyle
Fink, Whitney Cary, Kyle Hendrix, Geralyn
Annett, Audrey Torrest, Peter Deng, Josh
Gutierrez, Catherine Nacy, Karen Pepper,
Stefanos Kalomoiris, Johnathon Anderson,
Jeannine McGee, William Gruenloh, Brian
Fury, Gerhard Bauer, Alexandra Duffy,
Teresa Tempkin, Jan Nolta
5:15 p.m. S25.008
First-In-Human Stem Cell Trials in
Huntington’s Disease: A Bioethics
Survey —Alexandra Duffy, Teresa
Tempkin, Amanda Martin, Meaghan
O’Keefe, Marsha Michie, Mark Yarborough,
Vicki Wheelock
S26: Headache
3:30 p.m. Presentation of the Harold
Wolff-John Graham: An Award for
Headache/Facial Pain Research
Sponsored by the American Academy
of Neurology and endowed by Endo
Pharmaceuticals.
Recipient:
Catherine Chong, PhD
Phoenix, AZ
3:45 p.m. S26.002
Prevention of Episodic Migraine with
AMG 334, a Human Anti-Calcitonin
Gene-Related Peptide Receptor
Monoclonal Antibody: Phase 2 Study
Results and 52-Week Analysis of
Open-Label Extension —Robert Lenz,
David Dodick, Peter Goadsby, Stephen
Silberstein, Uwe Reuter, Messoud Ashina,
Joel Saper, Roger Cady, Feng Zhang,
Marie-Louise Trotman, Julie Dietrich,
Hong Sun
4:00 p.m. S26.003
Emotional Abuse History and Migraine
Among Young Adults: Results from The
Add Health Dataset —Gretchen Tietjen,
Monita Karmakar, Aliaksander Amialchuk
4:15 p.m. S26.004
Factors Predicting the Response
to the First Epidural Blood Patch
in Spontaneous Intracranial
Hypotension —Jr-Wei Wu, Shu-Shya
Hseu, Jong-Ling Fuh, Jiing-Feng Lirng, Yen-
Feng Wang, Wei-Ta Chen, Shuu-Jiun Wang
4:30 p.m. S26.005
Modifications of Gray Matter Volume
in Migraine Patients Over Four Years: A
Tensor-Based Morphometry Study —
Roberta Messina, Maria Rocca, Bruno
Colombo, Elisabetta Pagani, Andrea Falini,
Giancarlo Comi, Massimo Filippi
4:45 p.m. S26.006
Inflammation and Abnormal Trigeminal
Sensory Processing in Obese Mice —
Ana Recober-Montilla, Heather Rossi
5:00 p.m. S26.007
Peripheral and Central Nervous System
Distribution of a CGRP Neutralizing
Antibody [ 125 I]-LY2951742 in Male
Rats —Michael Johnson, Bernice Ellis,
Deanna Maren, S. Michelle Morin, Victor
Wroblewski, Kirk Johnson
5:15 p.m. S26.008
Delivery Outcomes After Acute
Migraine Treatment in Pregnancy —
Matthew Robbins, Tracy Grossman,
Shravya Govindappagari, Ashlesha Dayal
Plan Your Annual Meeting Experience with Convenient
Online Program Search
Planning your Annual Meeting week just got easier! Gain insight with helpful tips and suggested programs
that may be of most interest to you—and applicable to your career.
AAN.com/view/SearchAM
86 2016 AAN Annual Meeting Abstract Listing